Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV 33 )

Author： Goldstein G.   Manson K.   Tribbick G.   Smith R.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.18, Iss.25, 2000-06, pp. : 2789-2795

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Understanding the basis of CD4 + T-cell depletion in macaques infected by a simian-human immunodeficiency virus

By Etemad-Moghadam B.   Rhone D.   Steenbeke T.   Sun Y.   Manola J.   Gelman R.   Fanton J.W.   Racz P.   Tenner-Racz K.   Axthelm M.K.   Letvin N.L.   Sodroski J.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1934-1937

Elsevier

Access to resources Recommend Favorite

Specificity and effect on apoptosis of Tat antibodies from vaccinated and SHIV-infected rhesus macaques and HIV-infected individuals

By Belliard G.   Romieu A.   Zagury J.-F.   Dali H.   Chaloin O.   Le Grand R.   Loret E.   Briand J.-P.   Roques B.   Desgranges C.   Muller S.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3186-3199

Elsevier

Access to resources Recommend Favorite

Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques

By Fuller D.H.   Corb M.M.   Barnett S.   Steimer K.   Haynes J.R.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 924-926

Elsevier

Access to resources Recommend Favorite

Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection

By Gorse G.J.   Patel G.B.   Arbuckle J.A.   Belshe R.B.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 383-397

Elsevier

Access to resources Recommend Favorite

Simian immunodeficiency virus (SIV)-specific CD8 + cytotoxic T lymphocyte responses of naive and vaccinated cynomolgus macaques infected with SIVmac32H (J5): quantitative analysis by in vitro antigenic stimulation

By Geretti A.-M.   Hulskotte E.G.J.   Dings M.E.M.   van Baalen C.A.   van Amerongen G.   Osterhaus A.D.M.E.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1269-1275

Elsevier

Access to resources Recommend Favorite